284 related articles for article (PubMed ID: 29262667)
1. Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies.
Augsburger D; Nelson PJ; Kalinski T; Udelnow A; Knösel T; Hofstetter M; Qin JW; Wang Y; Gupta AS; Bonifatius S; Li M; Bruns CJ; Zhao Y
Oncotarget; 2017 Nov; 8(61):104638-104653. PubMed ID: 29262667
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
[TBL] [Abstract][Full Text] [Related]
3. Low-grade fibrosarcoma--report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types.
Hansen T; Katenkamp K; Brodhun M; Katenkamp D
Histopathology; 2006 Aug; 49(2):152-60. PubMed ID: 16879392
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Leiomyosarcoma With Malignant Transformation.
Malaviarachchi S; Balawardana J; Senanayake A; Perera R; Liyanage S
Cureus; 2021 Jan; 13(1):e12672. PubMed ID: 33604210
[TBL] [Abstract][Full Text] [Related]
5. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Jul; 43(1):39-49. PubMed ID: 23661254
[TBL] [Abstract][Full Text] [Related]
6. Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity.
Xu J; Du Y; Liu WJ; Li L; Li Y; Wang XF; Yi HF; Shan CK; Xia GM; Liu XJ; Zhen YS
Drug Deliv; 2018 Nov; 25(1):102-111. PubMed ID: 29250984
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma.
Chew W; Benson C; Thway K; Hayes A; Miah A; Zaidi S; Lee ATJ; Messiou C; Fisher C; van der Graaf WT; Jones RL
Med Oncol; 2018 Sep; 35(11):138. PubMed ID: 30187231
[TBL] [Abstract][Full Text] [Related]
8. The contribution of electron microscopy to the characterization of soft tissue fibrosarcomas.
Franchi A; Santucci M
Ultrastruct Pathol; 2013 Feb; 37(1):9-14. PubMed ID: 23383612
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2006; 23(1):105-11. PubMed ID: 16645235
[TBL] [Abstract][Full Text] [Related]
10. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells.
Thway K; Robertson D; Jones RL; Selfe J; Shipley J; Fisher C; Isacke CM
Br J Cancer; 2016 Aug; 115(4):473-9. PubMed ID: 27434038
[TBL] [Abstract][Full Text] [Related]
11. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis.
Brown GT; Murray GI
J Pathol; 2015 Nov; 237(3):273-81. PubMed ID: 26174849
[TBL] [Abstract][Full Text] [Related]
12. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
[TBL] [Abstract][Full Text] [Related]
13. Long-term Development of Fibrosarcoma in the Practice of Emergency Medical Teams: a Case Report.
Dudziński Ł; Czyżewski Ł; Kubiak T
Ortop Traumatol Rehabil; 2023 Apr; 25(2):97-104. PubMed ID: 37345628
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation.
Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C
Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139
[TBL] [Abstract][Full Text] [Related]
15. Recurrent RET fusions in fibrosarcoma-like neoplasms in adult viscera: expanding the clinicopathological and genetic spectrum.
Zhao M; Yin X; He H; Xia Q; Ru G
Histopathology; 2023 Mar; 82(4):633-645. PubMed ID: 36443894
[TBL] [Abstract][Full Text] [Related]
16. Cervical Infantile Fibrosarcoma: a rare cause of paediatric parapharyngeal neck mass.
Priya M; Singh P; Malhotra M; Angral S; Varshney S; Bhardwaj A; Tyagi AK; Kumar A; Gupta MK
Autops Case Rep; 2020 Nov; 10(4):e2020189. PubMed ID: 33344316
[TBL] [Abstract][Full Text] [Related]
17. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
Hung YP; Fletcher CDM; Hornick JL
Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
[TBL] [Abstract][Full Text] [Related]
19. Biological activity and clinical implications of the matrix metalloproteinases.
Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
[TBL] [Abstract][Full Text] [Related]
20. Soft tissue fibrosarcoma. A clinicopathologic study of 132 cases.
Scott SM; Reiman HM; Pritchard DJ; Ilstrup DM
Cancer; 1989 Aug; 64(4):925-31. PubMed ID: 2545330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
